Literature DB >> 6503501

[Effect of local moderate hyperthermia in combination with chemotherapy by N-nitroso-1,3-bis-(2-chloroethyl)urea (BCNU) on the descending colon of the rat with transplanted Yoshida sarcoma. 2. Monochemotherapy in combination with subsequent hyperthermia at various time intervals].

M Lorenz, E Biwer, M Habs, D Schmähl.   

Abstract

There are numerous reports on in vitro and in vivo investigations of hyperthermia for cytostasis of malignant tumors. Combination of chemotherapy and hyperthermia is to potentiate the therapeutic effect. The time interval between the two types of therapy was the main subject of the present investigation. Local hyperthermia (43 degrees C, 60 min) following BCNU chemotherapy at intervals of 0, 3, 6, 9, 12, and 24 h, respectively, was studied in a colonic Yoshida sarcoma model in Sprague-Dawley rats. No significant increase in the curing rate resulted from hyperthermic treatment. The results suggest that the highly anticipated hyperthermic peritoneal lavages should be investigated in controlled animal experiments prior to clinical use.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6503501     DOI: 10.1007/bf01254653

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN: 0023-8236


  29 in total

1.  Selective lethal effect of supranormal temperatures on human neoplastic cells.

Authors:  B C Giovanella; J S Stehlin; A C Morgan
Journal:  Cancer Res       Date:  1976-11       Impact factor: 12.701

2.  [Extreme hyperthermia studies on 4 different tumors in rats].

Authors:  D Schmähl; L Nöring
Journal:  Z Krebsforsch       Date:  1967

3.  Whole-body hyperthermia and chemotherapy for treatment of patients with advanced, refractory malignancies.

Authors:  T S Herman; C F Zukoski; R M Anderson; J J Hutter; C D Blitt; J M Malone; D F Larson; J C Dean; H B Roth
Journal:  Cancer Treat Rep       Date:  1982-02

4.  Potential for therapy of drugs and hyperthermia.

Authors:  G M Hahn
Journal:  Cancer Res       Date:  1979-06       Impact factor: 12.701

5.  Synergism between hyperthermia and cyclophosphamide in vivo: the effect of dose fractionation.

Authors:  G Hazan; E Ben-Hur; A Yerushalmi
Journal:  Eur J Cancer       Date:  1981-06       Impact factor: 9.162

6.  Tumor eradication by radiofrequency therapy. Responses in 21 patients.

Authors:  H H LeVeen; S Wapnick; V Piccone; G Falk
Journal:  JAMA       Date:  1976-05-17       Impact factor: 56.272

7.  [Effect of moderate local hyperthermia in combination with chemotherapy with cyclophosphamide or N-nitroso- 1,3-bis(2-chloroethyl)urea(BCNU) on Yoshida sarcoma implanted in the descending colon of rats. 1. Repeated hyperthermia within 8 days and combination of chemotherapy followed by hyperthermia 24 h later].

Authors:  M Lorenz; M Habs; D Schmähl
Journal:  Langenbecks Arch Chir       Date:  1983

8.  Effect of timing and sequence of hyperthermia and cyclophosphamide on a neurogenic rat tumor (BT4A) in vivo.

Authors:  O Dahl; O Mella
Journal:  Cancer       Date:  1983-09-15       Impact factor: 6.860

9.  Hyperthermia (42 degrees C) as an adjuvant to radiotherapy and chemotherapy in the treatment of the allogeneic VX2 carcinoma in the rabbit.

Authors:  D S Muckle; J A Dickson
Journal:  Br J Cancer       Date:  1973-04       Impact factor: 7.640

10.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1977-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.